A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
NCT05042193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1883
Last updated 2022-06-15
Summary
The primary objective of this study is to describe the longevity of IgG against SARS-CoV-2 infection or vaccination.
Conditions
- SARS-CoV-2 Acute Respiratory Disease
Interventions
- OTHER
-
SARS-CoV-2
Observational
Sponsors & Collaborators
-
Everly Health
lead INDUSTRY
Principal Investigators
-
Timothy Bauer, PhD · Everly Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-19
- Primary Completion
- 2022-05-31
- Completion
- 2022-06-14
Countries
- United States
Study Locations
More Related Trials
-
Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine
NCT04843917 ·Status: COMPLETED
-
Prognostic Value of IgM in Covid-19 Infection
NCT05092594 ·Status: UNKNOWN
-
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468 ·Status: COMPLETED
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain
NCT05087277 ·Status: UNKNOWN
-
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 ·Status: COMPLETED ·Phase: NA
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533 ·Status: COMPLETED ·Phase: NA
-
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206 ·Status: COMPLETED ·Phase: NA
-
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 ·Status: COMPLETED
-
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
NCT05774093 ·Status: RECRUITING
-
IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
NCT04402814 ·Status: UNKNOWN
-
COVID-19 in PID Survey
NCT04459689 ·Status: RECRUITING
-
COVID 19-Caregivers IGg Seroconversion
NCT04353323 ·Status: UNKNOWN
-
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers
NCT04525417 ·Status: COMPLETED ·Phase: NA
-
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 ·Status: TERMINATED
-
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 ·Status: COMPLETED
-
Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients
NCT04483622 ·Status: COMPLETED
-
Seroprevalence of Infection-induced SARS-CoV-2 Antibodies (COVID-19) in Children
NCT05358626 ·Status: COMPLETED
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients
NCT04524507 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts
NCT05094635 ·Status: UNKNOWN
-
The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults
NCT03798574 ·Status: COMPLETED
-
Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
NCT05305261 ·Status: COMPLETED
-
The Role of Obesity in Severe COVID-19 Pathophysiology
NCT06968442 ·Status: RECRUITING ·Phase: NA